Paeds SAQs · neurology-neurodisability-and-neuromuscular
Sleep disorders with neurological disease: SAQ
Short-answer questions on sleep disorders with neurological disease covering the four-cluster classification and the bidirectional mechanism, the investigation pathway from polysomnography to the multiple sleep latency test and cerebrospinal fluid orexin, and the stepped management built on sleep hygiene and behavioural therapy with melatonin, iron, airway support, and ventilation.
On this page & tools
Target exams
Question 1 (10 marks)
Outline your assessment and investigation of the boy with cerebral palsy, the likely diagnosis, and the principles of your management. (10 marks)
[7]Model answer
Likely diagnosis (2 marks). This boy has sleep-disordered breathing, most probably obstructive sleep apnoea with nocturnal hypoventilation, driven by the hypotonic airway collapse of his cerebral palsy and compounded by his oromotor dysfunction, scoliosis, and gastrostomy dependence. His increasing seizure frequency, morning headache, and daytime irritability are the daytime consequences of fragmented and hypoxic sleep, and they illustrate the bidirectional link, because his worsening seizures are both a result of and a contributor to his broken sleep. [7]
Assessment (3 marks). I would take a structured sleep history asking specifically about snoring, witnessed pauses, restless and sweaty sleep, morning mood, and daytime sleepiness, and I would use a validated instrument such as the Sleep Disturbance Scale for Children and a two-week sleep diary. The examination would target the drivers, mapping his oromotor function and tone, his adenotonsillar size, his scoliosis, and his weight and growth, and I would review his medications because sedating antiseizure medicines and baclofen may depress respiratory drive overnight. I would ask the family to film any events. [7] [9]
Investigation (2 marks). The gold-standard test is polysomnography scored by the American Academy of Sleep Medicine rules, which distinguishes obstructive from central events, quantifies the apnoea-hypopnoea index, and assesses for nocturnal hypoventilation with rising carbon dioxide and intermittent desaturation. Overnight pulse oximetry with capnography is a practical screening tool in the community and is particularly useful for monitoring a technology-dependent child over time and after any intervention. [11] [7]
Management (3 marks). Management is stepped and treats the airway and the neurology together. I would optimise his epilepsy and his reflux and constipation in parallel, because uncontrolled nocturnal seizures and reflux will defeat any sleep plan. Definitive treatment may include adenotonsillectomy in a carefully selected child, weighing the postoperative airway risk of a hypotonic child, and continuous positive airway pressure or bilevel non-invasive ventilation for the obstructive and hypoventilating child. He needs lifelong respiratory and sleep monitoring as he grows and after any surgery, and shared care between primary paediatrics, neurodisability, and the sleep service. [7]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References7Show ledgerHide ledger
- [1]Scammell TE Narcolepsy. N Engl J Med, 2015.PMID 26716917
- [2]Gringras P, Nir T, Breddy J, et al Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry, 2017.PMID 29096777
- [5]DelRosso LM, Ferri R, Chen ML, et al Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder. Sleep Med, 2021.PMID 34562823
- [7]Vanhaverbeke K, Selçuk M, Ersu R, et al. Sleep-disordered breathing in children with neurodisabilities. Eur Respir Rev, 2026.PMID 42128483
- [9]Wang H, Yu L, Hu S, et al Prevalence and associated factors of sleep disorders in children and adolescents with autism spectrum disorder: a meta-analysis and systematic review. BMC Psychiatry, 2026.PMID 42192550
- [11]Berry RB, Brooks R, Gamaldo C, et al AASM Scoring Manual updates for 2017 (version 2.4). J Clin Sleep Med, 2017.PMID 28416048
- [12]Dauvilliers Y, Mignot E, Del Rio Villegas R, et al Oral orexin receptor 2 agonist in narcolepsy type 1. N Engl J Med, 2023.PMID 37494485